Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

Several minimally invasive injectable modalities are safe and effective for the management of hair loss in adults with androgenetic alopecia.

Fructose, carbonated soft drinks, and free sugar consumption may be linked to asthma, allergic rhinitis, and food allergies in children.

Consensus recommendations have been established for pediatric mycosis fungoides, including additional clinical severity and outcome measures.

The United States government is offering another round of free COVID-19 tests, which will be available by the end of September.

Extreme temperature-related deaths are projected to increase considerably by the mid-21st century in the contiguous United States.

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

Topline results were announced from a trial evaluating dapirolizumab pegol in patients with moderate to severe systemic lupus erythematosus.

The FDA has accepted for filing the NDA for delgocitinib cream as a treatment for moderate to severe chronic hand eczema in adults.

The US Vaccines for Children program has prevented millions of cases of illness, hospitalizations, and deaths, resulting in massive direct and societal savings.

Treatment with baloxavir marboxil significantly reduced the risk of onward transmission of influenza within households.

Topline results were announced from a phase 3 trial evaluating rocatinlimab for the treatment of moderate to severe atopic dermatitis.